"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"
Transfuze a hematologie dnes · 2021
DOI: 10.48095/cctahd202163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2021. Verfasst von Angelika Bátorová und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bátorová, A., Prigancová, T., Jankovičová, D., & Kyselová, A. (2021). "Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia". Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd202163
Vancouver
Bátorová A, Prigancová T, Jankovičová D, Kyselová A. "Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia". Transfuze a hematologie dnes. 2021. doi:10.48095/cctahd202163
BibTeX
@article{Btorov2021,
author = {Bátorová, Angelika and Prigancová, Tatiana and Jankovičová, Denisa and Kyselová, Anna},
title = {"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"},
journal = {Transfuze a hematologie dnes},
year = {2021},
doi = {10.48095/cctahd202163}
}
EUVIMED